Rocket Lab’s Q2 performance reflected notable revenue growth, driven by strong momentum in its Space Systems segment and a surge in contract bookings from both government and commercial customers. Despite better-than-expected top line and non-GAAP earnings results, the market reacted negatively, with management attributing some margin pressure to integration costs from the Mynaric acquisition and a shift in business mix. CEO Peter Beck highlighted the company’s expanding backlog and key wins in satellite manufacturing, stating, “We achieved a record $234 million in Q2 revenue, up almost $90 million or 62% versus the same quarter last year.”

Is now the time to buy RKLB? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Rocket Lab’s Q2 Earnings Call

• Andres Sheppard-Slinger (Cantor Fitzgerald) asked about Neutron’s production ramp and ability to accelerate launches. CEO Peter Beck emphasized the focus on reliable scaling rather than just the first flight, and CFO Adam Spice noted pricing power due to industry constraints.

• Jeff Van Rhee (Craig-Hallum Capital Group) questioned how Rocket Lab will reaccelerate Iridium’s slower growth. Beck replied that the company intends to supercharge Iridium’s existing initiatives, especially in new application areas, and expects the acquisition to enhance Rocket Lab’s credibility with government clients.

• Trevor Walsh (Citizens) inquired about the financial profile and cost structure of GHOST-enabled launches. Spice responded that pricing should be consistent with HASTE missions, with potential for pricing upside as demand grows, and noted that associated capital expenditures are partially funded by customer contracts.

• Xin Yu (Deutsche Bank) asked about the timing and synergies for a next-generation Iridium constellation. Beck explained that while the current constellation is viable into the 2030s, Rocket Lab’s vertical integration positions it for future upgrades but details are premature.

• Kristine Liwag (Morgan Stanley) sought clarity on the drivers behind higher cash burn and the cadence of free cash flow improvement. Spice attributed cash outflows to Neutron development and Mynaric integration, projecting improvement post-Neutron’s first successful test flight.

Catalysts in Upcoming Quarters

In the upcoming quarters, our analyst team will closely track (1) the pace of Neutron’s development and the timing of its first flight, (2) integration milestones and early performance metrics from the Mynaric and pending Iridium acquisitions, and (3) the conversion of Rocket Lab’s expanding contract backlog into realized revenue. We will also monitor progress on new product rollouts, such as Flatellite and GHOST infrastructure, as key indicators of execution against management’s growth strategy.

Rocket Lab currently trades at $80.15, in line with $80.04 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.